Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03066648 |
| Title | Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | NLD | GBR | FRA | FIN | ESP | DEU | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
| Oregon Health Sciences University Main Center | Portland | Oregon | 97239 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| Novartis Investigative Site | Melbourne | Victoria | 3004 | Australia | Details | |
| Novartis Investigative Site | Helsinki | FIN 00290 | Finland | Details | ||
| Novartis Investigative Site | Marseille | 13273 | France | Details | ||
| Novartis Investigative Site | Dresden | 01307 | Germany | Details | ||
| Novartis Investigative Site | Jena | 07740 | Germany | Details | ||
| Novartis Investigative Site | Amsterdam | 1081 HV | Netherlands | Details | ||
| Novartis Investigative Site | Barcelona | Catalunya | 08036 | Spain | Details | |
| Novartis Investigative Site | Cardiff | CF4 4XN | United Kingdom | Details |